1.Efficacy and safety of PD-1/PD-L1 inhibitors in the treatment of recurrent and refractory ovarian cancer: A systematic review and a meta-analysis. Front Pharmacol. 2023 Mar 13;14:1111061. doi: 10.3389/fphar.2023.1111061. PMID: 36992842; PMCID: PMC10042289.

2.Efficacy and safety of minimally invasive surgery versus open laparotomy for interval debulking surgery of advanced ovarian cancer after neoadjuvant chemotherapy: a systematic review and a meta-analysis. Front.Oncol. 2022,12(7):900256

3.Association between inflammatory bowel disease and risk of abnormalities of uterine cervix. J.Obstet.Gynaecol.Res,2021,47(11):4030-4036

4. Effect of Rad18 suppresses cell proliferation of triple negative breast cancer through E2F3, FANCD2,Akt and cyclin D1 expression. Int J Clin Exp Pathol,2016,9(2):531-539

5.MCAF1/AM is involved in Sp1-mediated maintenance of cancer-associated telomerase activity. J Biol Chem. 2009,284 (8):5165-5174

6.腹腔镜在早期卵巢上皮性癌全面分期术中的应用, 大连医科大学学报, 2020,42（4）:343-347

7.IA2-IB1期宫颈癌宫旁转移相关因素分析, 大连医科大学学报, 2020,42（3）:235-238

8.卵巢Sertoli细胞瘤1例, 大连医科大学学报, 2018,40（2）:185-187

9.巧囊剥除术后3年内恶变1例, 大连医科大学学报, 2017,39（1）:101-102

10.Rad18缺失对雄小鼠生殖细胞的影响, 大连医科大学学报, 2012,34（3）:225-229

11.144例剖宫产指征分析, 大连医科大学学报, 2004,26（3）:200-201

12.妊娠合并特发性血小板减少性紫癜7例临床分析, 大连医科大学学报, 2002,24（2）:120-122

13.米非司酮对早孕妇女绒毛组织t-PA、PAI活性的影响, 中国计划生育学杂志, 1999,7（1）:14-15

细胞与分子免疫学（第9版），副主译，北京大学医学出版社，2022年3月1日，ISBN 978-7-5659-2547-4

大连市科技局计划项目：MCAF1在子宫颈癌发生中的作用机制及靶向治疗的可行性研究，编号2015E12SF145